NCT06237504View on ClinicalTrials.gov

The Clinical Efficacy of the Video Laryngeal Mask (SaCoVLM™) in Geriatric Patients: A Comparison With a Conventional Supraglottic Airway Device (Ambu®Auragain™)

NARecruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

ElderlyLaryngeal Mask AirwayGeneral Anesthesia

Interventions

DEVICE

SaCoVLM™

Patients will receive general anesthesia with their airways maintained with the SaCoVLM, which is a newer supraglottic airway device with a video port to directly visualize the upper airway.

DEVICE

Ambu®Auragain™

Patients will receive general anesthesia with their airways maintained with the Ambu Auragain, which is a conventional 2nd generation supraglottic airway device.

Trial Locations (1)

Unknown

RECRUITING

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT06237504 - The Clinical Efficacy of the Video Laryngeal Mask (SaCoVLM™) in Geriatric Patients: A Comparison With a Conventional Supraglottic Airway Device (Ambu®Auragain™) | Biotech Hunter | Biotech Hunter